共 25 条
[2]
[Anonymous], NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) with NCCN Evidence Blocks&TRADE
[3]
Czink E, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001974
[6]
PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
[J].
ONCOTARGET,
2017, 8 (15)
:24644-24651
[9]
KEYTRUDA (pembrolizumab), 2019, FULL PRESCR INF
[10]
Kim RD, 2019, J CLIN ONCOL S, V15, P4097